Pfizer wins another battle against generic drugs

23 November, 2005

Pfizer Inc. won against generic drugmaker Ranbaxy Laboratories Inc. in its battle to protect the patents of its drugs. A New Jersey court upheld a preliminary injunction late yesterday prohibiting India’s Ranbaxy from selling a generic version of Pfizer’s high blood pressure treatment, Accupril. The court also halted Israel’s Teva Pharmaceutical Industries Ltd. from marketing a generic version of the drug.

Pfizer’s vice chairman and general counsel, Jeff Kindler, said in a statement that the court’s resolution “sends a clear message that the law does not encourage or excuse infringement of valid pharmaceutical patents by generic companies.” The decision marks the second time this month that Pfizer won court rulings against Ranbaxy. Ranbaxy is the manufacturer of erectile dysfunction generic drug Caverta.


To read more visit:
http://www.newyorkbusiness.com/news.cms?id=12348